UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.78B |
| 2 |
NVIDIA
NVDA
|
+$3.34B |
| 3 |
Apple
AAPL
|
+$2.76B |
| 4 |
UBS Group
UBS
|
+$2.65B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.88B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.03B |
| 2 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.25B |
| 3 |
Pinduoduo
PDD
|
+$1.4B |
| 4 |
Linde
LIN
|
+$919M |
| 5 |
Prologis
PLD
|
+$865M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.34% |
| 2 | Healthcare | 12.59% |
| 3 | Financials | 12.08% |
| 4 | Consumer Discretionary | 10.26% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Paymentus
PAY
$4.86B
| $709K | ﹤0.01% |
37,295
+24,205
| +185% | +$474K |
|
2477
Spyre Therapeutics
SYRE
$9.25B
| $708K | ﹤0.01% |
+30,121
| New | +$1.02M |
|
|
ORLA
2478
DELISTED
Orla Mining
ORLA
| $707K | ﹤0.01% |
+184,203
| New | +$738K |
|
|
DCBO
2479
Docebo
DCBO
$566M
| $707K | ﹤0.01% |
+18,296
| New | +$751K |
|
|
YMAB
2480
DELISTED
Y-mAbs Therapeutics
YMAB
| $704K | ﹤0.01% |
+58,299
| New | +$787K |
|
2481
FRP Holdings
FRPH
$421M
| $701K | ﹤0.01% |
+24,594
| New | +$736K |
|
2482
Altimmune
ALT
$599M
| $699K | ﹤0.01% |
105,182
+86,982
| +478% | +$642K |
|
2483
Alector
ALEC
$199M
| $699K | ﹤0.01% |
153,981
+79,926
| +108% | +$411K |
|
2484
Vishay Precision Group
VPG
$914M
| $694K | ﹤0.01% |
22,814
+9,781
| +75% | +$321K |
|
|
TRTX
2485
TPG RE Finance Trust
TRTX
$618M
| $693K | ﹤0.01% |
80,261
-28,479
| -26% | -$234K |
|
2486
Hagerty
HGTY
$1.39B
| $692K | ﹤0.01% |
66,553
+45,698
| +219% | +$424K |
|
2487
Disc Medicine
IRON
$2.97B
| $691K | ﹤0.01% |
15,337
+10,487
| +216% | +$356K |
|
|
TIXT
2488
DELISTED
TELUS International
TIXT
| $691K | ﹤0.01% |
+119,570
| New | +$836K |
|
2489
Designer Brands
DBI
$333M
| $690K | ﹤0.01% |
101,073
+32,604
| +48% | +$288K |
|
2490
FLEX LNG
FLNG
$1.67B
| $690K | ﹤0.01% |
+25,501
| New | +$692K |
|
2491
EyePoint Inc
EYPT
$1.2B
| $689K | ﹤0.01% |
79,246
+69,146
| +685% | +$966K |
|
|
ONC
2492
BeOne Medicines Ltd
ONC
$39.4B
| $686K | ﹤0.01% |
4,807
+2,418
| +101% | +$373K |
|
2493
Nuvation Bio
NUVB
$2.32B
| $684K | ﹤0.01% |
+234,289
| New | +$715K |
|
|
RPC
2494
Ridgepost Capital
RPC
$991M
| $678K | ﹤0.01% |
+79,948
| New | +$638K |
|
2495
Standard BioTools
LAB
$314M
| $677K | ﹤0.01% |
382,488
+278,428
| +268% | +$681K |
|
2496
Warner Music
WMG
$13.8B
| $677K | ﹤0.01% |
+22,086
| New | +$709K |
|
2497
Tango Therapeutics
TNGX
$4.41B
| $675K | ﹤0.01% |
78,722
+66,522
| +545% | +$514K |
|
|
JOYY
2498
JOYY Inc
JOYY
$3.75B
| $675K | ﹤0.01% |
22,417
-38,902
| -63% | -$1.24M |
|
2499
Bally's
BALY
$658M
| $673K | ﹤0.01% |
56,260
+22,061
| +65% | +$282K |
|
2500
Kearny Financial
KRNY
$599M
| $663K | ﹤0.01% |
107,788
+35,675
| +49% | +$204K |
|
Similar funds
UBS AM's Q2 2024 Portfolio in Review
As of Q2 2024, UBS AM held 2,913 positions worth $349B, up 24% from $281B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
UBS AM deployed $57B of net new capital in Q2 2024, opening 370 new positions and adding to 2,061 existing holdings. Its largest new stake was UBS Group: 89,043,128 shares worth $2.63B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core MSCI EAFE ETF, an estimated $4.03B trimmed.
- UBS AM's largest Q2 2024 buy was UBS Group: 89,043,128 shares worth $2.63B.
- UBS AM added most to Microsoft in Q2 2024, an estimated $4.78B increase.
- UBS AM's biggest Q2 2024 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $4.03B.
- UBS AM fully exited iShares Broad USD Investment Grade Corporate Bond ETF in Q2 2024, selling an estimated $2.25B.
- UBS AM's ten largest holdings make up 31% of its $349B portfolio in Q2 2024.
- UBS AM opened 370 new positions and closed 119 in Q2 2024.
- UBS AM's portfolio value rose 24% quarter-over-quarter to $349B.
Based on UBS AM's 13F filing for Q2 2024, filed 14 Aug 2024.